Serge Lepage
Quebec, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Author Correction to "Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]".
Journal: The Canadian journal of cardiology
Published: April 09, 2026
Evolving Heart Failure Profiles in Quebec from 1998-2021: Insights from the Vision C+ Database.
Journal: CJC open
Published: March 11, 2026
Author Correction to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%): [Canadian Journal of Cardiology. Volume 41, Issue 10, Pages 1857-1874. DOI:10.1016/j.cjca.2025.07.027].
Journal: The Canadian journal of cardiology
Published: January 01, 2026
Corrigendum to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%).: Volume 41, Issue 10, October 2025, Pages 1857-74.
Journal: The Canadian journal of cardiology
Published: December 21, 2025
Vaccination in Patients with Cardiovascular Disease: A Case-Based Approach and Contemporary Review.
Journal: CJC open
Published: August 02, 2025
The Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) Trial-IMAGE HF Project 1A.
Journal: CJC open
Published: April 25, 2025
Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%).
Journal: The Canadian journal of cardiology
Published: March 10, 2025
In-Hospital or Out-of-Hospital Initiation of Sacubitril/Valsartan Versus Valsartan in Patients With Mildly Reduced or Preserved Ejection Fraction After A Worsening Heart Failure Event: The PARAGLIDE-HF Trial.
Journal: Journal of the American Heart Association
Published: February 19, 2025
Sacubitril/valsartan versus valsartan initiation in patients naïve to renin-angiotensin system inhibitors: Insights from PARAGLIDE-HF.
Journal: European journal of heart failure
Published: May 02, 2024
Effects of Sacubitril/Valsartan vs Valsartan in De Novo vs Acute on Chronic HFpEF and HFmrEF.
Journal: JACC. Advances
Published: January 17, 2024
Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure.
Journal: Journal of the American College of Cardiology
Published: November 02, 2023
Last Updated: 09/26/2026